A Study of the Relationship Between Cystatin C and Metabolic Bone Disease in Preterm Infants

A Study of the Relationship Between Cystatin C and Metabolic Bone Disease in Preterm Infants

Cystatin C (CysC) is commonly used as a marker of renal failure in premature infants. The aim of this study was to investigate serum CysC levels in osteopenia of prematurity (OP) and determine whether CysC could be safely used as a marker of renal insufficiency in infants with OP. Subjects were 50 p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical research in pediatric endocrinology 2018-06, Vol.10 (2), p.119-124
Hauptverfasser: Korkut, Sabriye, Memur, Şeyma, Halis, Hülya, Baştuğ, Osman, Korkmaz, Levent, Özdemir, Ahmet, Güneş, Tamer, Öztürk, Mehmet Adnan, Kurtoğlu, Selim
Format: Artikel
Sprache:eng
Schlagworte:
Age
Biological markers
Bone density
Bone diseases
Congenital diseases
Fractures
Hemoglobin
Kidneys
Metabolism
Mineralization
Newborn babies
Original
Osteopenia
Premature babies
Sepsis
Standard deviation
Studies
Tıp
Ultrasonic imaging
Values
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cystatin C (CysC) is commonly used as a marker of renal failure in premature infants. The aim of this study was to investigate serum CysC levels in osteopenia of prematurity (OP) and determine whether CysC could be safely used as a marker of renal insufficiency in infants with OP. Subjects were 50 preterm infants (≤32 gestational weeks). Calcium (Ca), phosphorus (P) and alkaline phosphatase (ALP) serum levels were measured in postnatal week nine, and bone density was measured concurrently by quantitative ultrasonography. Patients with a Z score of
ISSN:1308-5727
1308-5735
DOI:10.4274/jcrpe.2088